SCIPLAY CORP-CLASS A (SCPL)

US8090871091 - Common Stock

22.94  0 (0%)

After market: 22.94 0 (0%)

Fundamental Rating

7

Taking everything into account, SCPL scores 7 out of 10 in our fundamental rating. SCPL was compared to 72 industry peers in the Entertainment industry. SCPL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. SCPL has a decent growth rate and is not valued too expensively. This makes SCPL very considerable for quality investing!



8

1. Profitability

1.1 Basic Checks

SCPL had positive earnings in the past year.
SCPL had a positive operating cash flow in the past year.
SCPL had positive earnings in each of the past 5 years.
SCPL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

SCPL has a better Return On Assets (2.81%) than 80.26% of its industry peers.
SCPL has a Return On Equity of 20.14%. This is amongst the best in the industry. SCPL outperforms 96.05% of its industry peers.
SCPL has a Return On Invested Capital of 16.88%. This is amongst the best in the industry. SCPL outperforms 98.68% of its industry peers.
SCPL had an Average Return On Invested Capital over the past 3 years of 20.75%. This is significantly below the industry average of 86.07%.
Industry RankSector Rank
ROA 2.81%
ROE 20.14%
ROIC 16.88%
ROA(3y)3.14%
ROA(5y)7.57%
ROE(3y)22.07%
ROE(5y)30.85%
ROIC(3y)20.75%
ROIC(5y)25.04%

1.3 Margins

SCPL has a better Profit Margin (3.21%) than 80.26% of its industry peers.
SCPL's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 22.59%, SCPL belongs to the best of the industry, outperforming 97.37% of the companies in the same industry.
SCPL's Operating Margin has improved in the last couple of years.
The Gross Margin of SCPL (69.31%) is better than 85.53% of its industry peers.
SCPL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.59%
PM (TTM) 3.21%
GM 69.31%
OM growth 3Y0.07%
OM growth 5Y11.46%
PM growth 3Y-21.71%
PM growth 5Y-12.18%
GM growth 3Y1.8%
GM growth 5Y2.46%

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SCPL is creating value.
SCPL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SCPL has been reduced compared to 5 years ago.
SCPL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

SCPL has an Altman-Z score of 4.65. This indicates that SCPL is financially healthy and has little risk of bankruptcy at the moment.
SCPL has a Altman-Z score of 4.65. This is amongst the best in the industry. SCPL outperforms 86.84% of its industry peers.
There is no outstanding debt for SCPL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.65
ROIC/WACC1.74
WACC9.7%

2.3 Liquidity

A Current Ratio of 7.32 indicates that SCPL has no problem at all paying its short term obligations.
SCPL has a Current ratio of 7.32. This is amongst the best in the industry. SCPL outperforms 96.05% of its industry peers.
SCPL has a Quick Ratio of 7.32. This indicates that SCPL is financially healthy and has no problem in meeting its short term obligations.
SCPL has a better Quick ratio (7.32) than 96.05% of its industry peers.
Industry RankSector Rank
Current Ratio 7.32
Quick Ratio 7.32

6

3. Growth

3.1 Past

SCPL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.49%, which is quite impressive.
Measured over the past years, SCPL shows a very strong growth in Earnings Per Share. The EPS has been growing by 39.87% on average per year.
SCPL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.78%.
SCPL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.17% yearly.
EPS 1Y (TTM)36.49%
EPS 3Y7.53%
EPS 5Y39.87%
EPS Q2Q%8.7%
Revenue 1Y (TTM)17.78%
Revenue growth 3Y12.94%
Revenue growth 5Y13.17%
Sales Q2Q%18.61%

3.2 Future

SCPL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.63% yearly.
The Revenue is expected to grow by 5.38% on average over the next years.
EPS Next Y6.91%
EPS Next 2Y12.81%
EPS Next 3Y13.63%
EPS Next 5YN/A
Revenue Next Year12.54%
Revenue Next 2Y8.11%
Revenue Next 3Y6.52%
Revenue Next 5Y5.38%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.71, which indicates a rather expensive current valuation of SCPL.
Based on the Price/Earnings ratio, SCPL is valued cheaper than 84.21% of the companies in the same industry.
SCPL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 19.38, which indicates a rather expensive current valuation of SCPL.
Based on the Price/Forward Earnings ratio, SCPL is valued a bit cheaper than the industry average as 76.32% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SCPL to the average of the S&P500 Index (22.83), we can say SCPL is valued inline with the index average.
Industry RankSector Rank
PE 22.71
Fwd PE 19.38

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SCPL is valued a bit cheaper than 72.37% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SCPL is valued cheaply inside the industry as 86.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.8
EV/EBITDA 13.3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SCPL does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of SCPL may justify a higher PE ratio.
SCPL's earnings are expected to grow with 13.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.29
PEG (5Y)0.57
EPS Next 2Y12.81%
EPS Next 3Y13.63%

0

5. Dividend

5.1 Amount

No dividends for SCPL!.
Industry RankSector Rank
Dividend Yield N/A

SCIPLAY CORP-CLASS A

NASDAQ:SCPL (10/20/2023, 8:09:56 PM)

After market: 22.94 0 (0%)

22.94

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-08 2023-08-08/amc
Earnings (Next)11-07 2023-11-07/amc
Inst Owners0.82%
Inst Owner Change0%
Ins Owners0.4%
Ins Owner Change0%
Market Cap2.87B
Analysts52.31
Price Target21.63 (-5.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.92%
Min EPS beat(2)-5.63%
Max EPS beat(2)-2.21%
EPS beat(4)0
Avg EPS beat(4)-4.39%
Min EPS beat(4)-5.63%
Max EPS beat(4)-2.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.97%
Min Revenue beat(2)1.86%
Max Revenue beat(2)4.08%
Revenue beat(4)4
Avg Revenue beat(4)1.56%
Min Revenue beat(4)0.06%
Max Revenue beat(4)4.08%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.93%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.05%
Valuation
Industry RankSector Rank
PE 22.71
Fwd PE 19.38
P/S 3.94
P/FCF 17.8
P/OCF 16.12
P/B 24.71
P/tB N/A
EV/EBITDA 13.3
EPS(TTM)1.01
EY4.4%
EPS(NY)1.18
Fwd EY5.16%
FCF(TTM)1.29
FCFY5.62%
OCF(TTM)1.42
OCFY6.2%
SpS5.83
BVpS0.93
TBVpS-1.37
PEG (NY)3.29
PEG (5Y)0.57
Profitability
Industry RankSector Rank
ROA 2.81%
ROE 20.14%
ROCE 21.37%
ROIC 16.88%
ROICexc 34.62%
ROICexgc 147.69%
OM 22.59%
PM (TTM) 3.21%
GM 69.31%
FCFM 22.12%
ROA(3y)3.14%
ROA(5y)7.57%
ROE(3y)22.07%
ROE(5y)30.85%
ROIC(3y)20.75%
ROIC(5y)25.04%
ROICexc(3y)44.86%
ROICexc(5y)42.21%
ROICexgc(3y)160.44%
ROICexgc(5y)734.81%
ROCE(3y)26.27%
ROCE(5y)31.7%
ROICexcg growth 3Y21.69%
ROICexcg growth 5Y-39.38%
ROICexc growth 3Y-2.24%
ROICexc growth 5Y5.21%
OM growth 3Y0.07%
OM growth 5Y11.46%
PM growth 3Y-21.71%
PM growth 5Y-12.18%
GM growth 3Y1.8%
GM growth 5Y2.46%
F-Score9
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 78.5%
Cap/Sales 2.3%
Interest Coverage 250
Cash Conversion 95.7%
Profit Quality 689.32%
Current Ratio 7.32
Quick Ratio 7.32
Altman-Z 4.65
F-Score9
WACC9.7%
ROIC/WACC1.74
Cap/Depr(3y)61.88%
Cap/Depr(5y)66.91%
Cap/Sales(3y)1.48%
Cap/Sales(5y)1.43%
Profit Quality(3y)771.01%
Profit Quality(5y)552.22%
High Growth Momentum
Growth
EPS 1Y (TTM)36.49%
EPS 3Y7.53%
EPS 5Y39.87%
EPS Q2Q%8.7%
EPS Next Y6.91%
EPS Next 2Y12.81%
EPS Next 3Y13.63%
EPS Next 5YN/A
Revenue 1Y (TTM)17.78%
Revenue growth 3Y12.94%
Revenue growth 5Y13.17%
Sales Q2Q%18.61%
Revenue Next Year12.54%
Revenue Next 2Y8.11%
Revenue Next 3Y6.52%
Revenue Next 5Y5.38%
EBIT growth 1Y7.93%
EBIT growth 3Y13.02%
EBIT growth 5Y26.14%
EBIT Next Year38.34%
EBIT Next 3Y16.01%
EBIT Next 5Y12.36%
FCF growth 1Y-7.93%
FCF growth 3Y18.16%
FCF growth 5Y19.58%
OCF growth 1Y-4.35%
OCF growth 3Y17.38%
OCF growth 5Y19.31%